Breaking News Instant updates and real-time market news.

TSLA

Tesla

$308.35

12.89 (4.36%)

, F

Ford

$11.14

0.14 (1.27%)

12:44
05/07/17
05/07
12:44
05/07/17
12:44

General Motors, Ford could swing into favor, Tesla could slump, Barron's says

The potential slowdown indicated by April sales numbers from the major automakers could in fact be good news for Ford (F) and GM (GM), Barron's contends in a feature article. Investors tend to value carmakers and other cyclical companies on trough earnings, and the revamped, cost-conscious industry now has an opportunity to prove it can remain profitable in a slump, the publication explains. Tesla (TSLA), meanwhile, fell 2% last week after warning of "brand confusion" related to its mass-market Model 3, and the launch of the car could hurt the priced-for-perfection stock, Barron's says. Reference Link

TSLA

Tesla

$308.35

12.89 (4.36%)

F

Ford

$11.14

0.14 (1.27%)

GM

General Motors

$33.77

0.62 (1.87%)

  • 11

    May

  • 30

    May

  • 06

    Jun

TSLA Tesla
$308.35

12.89 (4.36%)

05/05/17
SBSH
05/05/17
NO CHANGE
SBSH
Netflix tops Citi's list of potential takeover targets for Apple
With over 90% of Apple's (AAPL) nearly $250B of cash sitting overseas, a one-time 10% repatriation tax would give the company $220B for acquisitions or buybacks, Citi analyst Jim Suva tells investors in a research note titled "Addressing the Problem of Too Much Cash." The analyst identified seven potential takeover targets for the iPhone market using five filters: strategic fit, global scale, transaction size, few non-strategic assets and the likely impact on Apple's share price. The analyst's potential targets for Apple are Netflix (NFLX), Disney (DIS), Hulu, Activision Blizzard (ATVI), Electronic Arts (EA), Take-Two Interactive (TTWO) and Tesla (TSLA). Each of these names bring some strategic benefit to Apple, Suva argues. The analyst gave Netflix the highest likelihood of being acquired with a 40% probability. Disney is next at 25%, with the rest at 10% or below. Suva believes a hybrid approach to the large cash position may be Apple's best path. The iPhone maker, for example, could acquire Netflix with one-third of the cash and use the remaining two-thirds for buybacks, Suva contends.
05/04/17
05/04/17
NO CHANGE

Bernstein worried about slowing demand for Tesla Model S, Model X
Bernstein analyst A.M. Sacconaghi, Jr is more worried about slowing demand for Tesla's Model S and Model X vehicles after the company reported that its deposits fell $48M last quarter versus the previous quarter. The analyst is also worried that Tesla will experience gross margin pressure in 2H17 as the Model 3 ramps and its depreciation expense increases significantly. Sacconaghi, Jr says that Tesla appears to be "fairly to modestly overvalued at current levels" and keeps a Market Perform rating on the shares.
05/04/17
BARD
05/04/17
NO CHANGE
Target $368
BARD
Outperform
Continued execution will drive Tesla shares higher, says Baird
Baird analyst Ben Kallo said Tesla shares should be bought at current levels following solid Q1 results. The analyst said the company beat estimates, displayed strong automotive and Telsa Energy margins, kept Model 3 production on track for July, and should ramp production of the Model 3 to around 5,000 vehicles per week by the end of the year. Kallo believes continued execution will continue to drive the shares higher. Kallo reiterated his Outperform rating and $368 price target on Tesla shares.
05/04/17
LEHM
05/04/17
NO CHANGE
Target $165
LEHM
Overweight
Barclays points out the negatives in Tesla's quarter
While auto gross margin was good at 27.8%, Tesla's Q1 earnings were below consensus and $650M of the $1.25B the carmaker raised in its March offering has been burned, Barclays analyst Brian Johnson tells investors in a post-earnings research note titled "Enlightened but not ignorant." Further, customer deposits were down nearly $50M in the quarter, the analyst adds. Johnson says that while recent conversations with Tesla bulls left him "enlightened," he still wanted to point out the negatives in the quarter. The analyst keeps an Underweight rating on the shares with a $165 price target. The stock, despite being fundamentally overvalued, can "continue to work" over the next few months given the media hype surrounding the Model 3 launch, Johnson writes. Tesla in premarket trading is down 2%, or $6.02, to $305.00 following last night's earnings report.
F Ford
$11.14

0.14 (1.27%)

05/02/17
JPMS
05/02/17
NO CHANGE
JPMS
Overweight
Ford truck demand healthy in April, says JPMorgan
JPMorgan analyst Ryan Brinkman noted that Ford's April sales of its least profitable class of vehicles - cars - fell by about 18% compared to last year, while its most profitable segment - trucks- declined by "a much more modest" 0.6% and F-Series sales rose 3.7% from last April. Ford's average transaction prices increased strongly and by a good deal more than the industry, Brinkman also noted. He keeps an Overweight rating on Ford shares, which are down about 4% in afternoon trading.
02/26/17
GSCO
02/26/17
DOWNGRADE
Target $41
GSCO
Neutral
Allison Transmission downgraded to Neutral from Buy at Goldman
Goldman Sachs analyst Jerry Revich downgraded Allison Transmission (ALSN) to Neutral from Buy with an unchanged price target of $41. The manufacturer of fully-automatic transmissions for trucks closed Friday up 24c to $36.79. The stock, currently trading at an 8% free cash flow yield versus 13% in Sept. 2013, offers limited upside and a balanced risk/reward profile, Revich tells investors in a research note. He also believes that the range of competitive transmission options is rising. Ford (F) is gaining share with its automotive engine and transmission, Revich points out.
02/10/17
02/10/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ford (F) upgraded to Hold from Underperform at Jefferies with analyst Philippe Houchois upgraded Ford (F) Motor to Hold saying the company's "bad news" in the last six months has been sufficiently priced into the shares. While cyclical risks remain, Ford should benefit the most of the big three from infrastructure spending, border adjusted tax reform and exposure to a Russian auto recovery, Houchois tells investors in a research note. He raised his price target for the shares to $12 from $10. 2. CSX (CSX) upgraded to Outperform from Market Perform at Avondale. 3. Jack in the Box (JACK) upgraded to Buy from Hold at SunTrust with analyst Jake Bartlett saying he expects the company to benefit from fewer discounts in the sector and market share gains going forward. 4. Cigna (CI) upgraded to Outperform from Sector Perform at RBC Capital with analyst Frank Morgan saying the company is well positioned as a standalone entity. The analyst believes Cigna has "multiple positive levers" to drive earnings higher and sees a likelihood for "significant" capital deployment. Morgan raised his price target for the shares to $172 from $151. 5. Enerplus (ERF) upgraded to Outperform from Market Perform at BMO Capital with analyst Ray Kwan citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/10/17
JEFF
02/10/17
NO CHANGE
Target $36
JEFF
Hold
Jefferies switches preference to Ford from General Motors
Jefferies analyst Philippe Houchois switched his preference to Ford Motor (F) shares from General Motors (GM) after upgrading the former to Hold. The analyst keeps a Hold rating on GM with a $36 price target. Matching last years' $6B-plus adjusted free cash "is looking challenging," Houchois tells investors in a research note.
GM General Motors
$33.77

0.62 (1.87%)

05/02/17
JPMS
05/02/17
NO CHANGE
JPMS
Overweight
General Motors April sales only modestly softer, says JPMorgan
JPMorgan analyst Ryan Brinkman views General Motors' April sales report as only modestly softer than expected as the the lower unit sales can be largely explained by a decline in less profitable sales to fleet customers. Of more concern is the fall-off in segment mix, but average transaction prices continue to rise, Brinkman tells investors in a research note. He keeps on Overweight rating on GM.
04/25/17
JPMS
04/25/17
NO CHANGE
Target $48
JPMS
Overweight
GM Supreme Court ruling an 'incremental negative,' says JPMorgan
JPMorgan analyst Ryan Brinkman views the Supreme Court's decision to not hear and review General Motors' appeal regarding an earlier decision by a lower court to allow liability lawsuits to proceed against the company for deaths, injuries and economic value losses associated with vehicles sold prior to its bankruptcy in 2009 as an "incremental negative." The judgement significantly reduces the likelihood of a quick resolution of the pending lawsuits, but does not materially change the likelihood of GM having to pay further liabilities, Brinkman tells investors in a research note. He believes the news is a not a "game changer" for GM. The analyst keeps an Overweight rating on the shares with a $48 price target.
04/24/17
BOFA
04/24/17
NO CHANGE
Target $42
BOFA
Neutral
General Motors Q1 likely strong but strength may fade, says BofA/Merrill
BofA/Merrill analyst John Murphy said General Motors' Q1 is set up to be another strong quarter driven by a production/inventory build in North America ahead of crossover launches and K2XX downtime. However, the analyst has a more conservative view of current industry environment and notes managements comments on potential challenges to its outlook including growth in South American and in adjacent businesses. Murphy rates General Motors a Neutral with a $42 price target.
03/29/17
RBCM
03/29/17
NO CHANGE
Target $37
RBCM
Sector Perform
General Motors two class stock proposal a 'non-starter,' says RBC Capital
RBC Capital analyst Joseph Spak noted that the rating agencies have indicated that the Greenlight Capital's proposed "dividend" shares would be treated as General Motors debt for credit metric purposes, meaning GM would lose its investment grade rating if it pursued Einhorn's plan, which he believes makes the proposal a "non-starter." If GM successfully builds out its mobility solutions and services, Spak thinks a tracking stock on those could be an alternative to unlock value, he tells investors. Spak keeps a Sector Perform rating and $37 price target on GM shares.

TODAY'S FREE FLY STORIES

VZ

Verizon

, LOGI

Logitech

$37.58

0.25 (0.67%)

09:17
01/23/18
01/23
09:17
01/23/18
09:17
Hot Stocks
On The Fly: Pre-market Movers »

UP AFTER EARNINGS:…

VZ

Verizon

LOGI

Logitech

$37.58

0.25 (0.67%)

JNJ

Johnson & Johnson

NFLX

Netflix

$227.58

7.12 (3.23%)

HBAN

Huntington Bancshares

$16.03

0.22 (1.39%)

KMB

Kimberly-Clark

RMD

ResMed

AMTD

TD Ameritrade

$55.88

0.71 (1.29%)

ATI

Allegheny Technologies

TSLA

Tesla

$351.56

1.54 (0.44%)

AAPL

Apple

$177.00

-1.46 (-0.82%)

PG

Procter & Gamble

ADMS

Adamas Pharmaceuticals

$40.79

2.6 (6.81%)

GPRO

GoPro

$6.30

0.01 (0.16%)

TWTR

Twitter

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 30

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 08

    Feb

  • 16

    Feb

  • 16

    Feb

  • 28

    Feb

  • 08

    Mar

  • 24

    Jan

NBL

Noble Energy

09:16
01/23/18
01/23
09:16
01/23/18
09:16
Recommendations
Noble Energy analyst commentary  »

Noble Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

JNJ

Johnson & Johnson

09:16
01/23/18
01/23
09:16
01/23/18
09:16
Hot Stocks
Johnson & Johnson sees apalutamide approval in 2018 »

Johnson & Johnson CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

ABEO

Abeona Therapeutics

$14.85

0.25 (1.71%)

09:16
01/23/18
01/23
09:16
01/23/18
09:16
Initiation
Abeona Therapeutics initiated  »

Abeona Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

EOG

EOG Resources

09:15
01/23/18
01/23
09:15
01/23/18
09:15
Recommendations
EOG Resources analyst commentary  »

EOG Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

FANG

Diamondback Energy

$132.21

4.64 (3.64%)

09:13
01/23/18
01/23
09:13
01/23/18
09:13
Recommendations
Diamondback Energy analyst commentary  »

Diamondback Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

09:13
01/23/18
01/23
09:13
01/23/18
09:13
Hot Stocks
Twitter drops as COO Anthony Noto resigns to become SoFi CEO »

Shares of Twitter (TWTR)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

AMRN

Amarin

$4.04

0.07 (1.76%)

09:12
01/23/18
01/23
09:12
01/23/18
09:12
Recommendations
Amarin analyst commentary  »

Amarin shares have room…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVN

Devon Energy

09:12
01/23/18
01/23
09:12
01/23/18
09:12
Recommendations
Devon Energy analyst commentary  »

Devon Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TWTR

Twitter

09:12
01/23/18
01/23
09:12
01/23/18
09:12
Technical Analysis
Technical Take: Twitter drops on departure of COO Anthony Noto »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

CLR

Continental Resources

09:11
01/23/18
01/23
09:11
01/23/18
09:11
Recommendations
Continental Resources analyst commentary  »

Continental Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

09:10
01/23/18
01/23
09:10
01/23/18
09:10
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CXO

Concho Resources

$160.41

4.22 (2.70%)

09:10
01/23/18
01/23
09:10
01/23/18
09:10
Recommendations
Concho Resources analyst commentary  »

Concho Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

VZ

Verizon

$53.46

1.55 (2.99%)

09:09
01/23/18
01/23
09:09
01/23/18
09:09
Technical Analysis
Technical Take: Verizon trades higher after results »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

ANAB

AnaptysBio

$114.78

-0.135 (-0.12%)

09:08
01/23/18
01/23
09:08
01/23/18
09:08
Recommendations
AnaptysBio analyst commentary  »

AnaptysBio price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XEC

Cimarex Energy

$126.80

2.76 (2.23%)

09:08
01/23/18
01/23
09:08
01/23/18
09:08
Recommendations
Cimarex Energy analyst commentary  »

Cimarex Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 15

    Feb

DGX

Quest Diagnostics

$103.57

0.51 (0.49%)

09:08
01/23/18
01/23
09:08
01/23/18
09:08
Hot Stocks
Quest Diagnostics to acquire MedXM for undisclosed amount »

Quest Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

VZ

Verizon

$53.46

1.55 (2.99%)

09:07
01/23/18
01/23
09:07
01/23/18
09:07
Hot Stocks
Breaking Hot Stocks news story on Verizon »

Verizon says FY18 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

SLB

Schlumberger

$79.79

3.37 (4.41%)

09:06
01/23/18
01/23
09:06
01/23/18
09:06
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$60.72

2.52 (4.33%)

09:06
01/23/18
01/23
09:06
01/23/18
09:06
Recommendations
Anadarko analyst commentary  »

Anadarko price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

VZ

Verizon

$53.46

1.55 (2.99%)

09:06
01/23/18
01/23
09:06
01/23/18
09:06
Hot Stocks
Breaking Hot Stocks news story on Verizon »

Verizon says 5G trials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

TWTR

Twitter

$23.32

-0.34 (-1.44%)

09:05
01/23/18
01/23
09:05
01/23/18
09:05
Hot Stocks
SoFi names former Twitter COO Anthony Noto as CEO »

SoFi announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

HAL

Halliburton

$56.40

3.39 (6.40%)

09:05
01/23/18
01/23
09:05
01/23/18
09:05
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$91.89

0.82 (0.90%)

09:04
01/23/18
01/23
09:04
01/23/18
09:04
Hot Stocks
Procter & Gamble sees stronger earnings growth in Q4 than Q3 »

Views tax act as a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 16

    Feb

WPP

WPP

$95.32

-0.21 (-0.22%)

09:04
01/23/18
01/23
09:04
01/23/18
09:04
Downgrade
WPP rating change  »

WPP downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.